Neoadjuvant Phase II Studies of Modified Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Cancer

被引：2
|
作者：
Adesunloye, Bamidele A. [1 ]
机构：
[1] Indiana Univ Sch Med, Lafayette, IN 46202 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 36期
关键词：
CHEMOTHERAPY; MULTICENTER; GEMCITABINE;
D O I：
10.1200/JCO.2014.57.9318
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4170 / U405
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant Phase II Studies of Modified Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Cancer Reply
    Plimack, Elizabeth R.
    Hoffman-Censits, Jean
    Rosenberg, Jonathan E.
    Wong, Yu-Ning
    Bellmunt, Joaquim
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (36) : 4171 - U408
  • [2] NEOADJUVANT DOSE-DENSE METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN FOR MUSCLE-INVASIVE BLADDER CANCER.
    van de Putte, Elisabeth E. Fransen
    Mertens, Laura S.
    Meijer, Richard P.
    van der Heijden, Michiel S.
    Kerst, J. Martijn
    Bergman, Andries M.
    Horenblas, Simon
    van Rhijn, Bas W. G.
    JOURNAL OF UROLOGY, 2015, 193 (04): : E703 - E703
  • [3] Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial
    LANCET, 1999, 354 (9178): : 533 - 540
  • [4] Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer
    Galsky, Matthew D.
    Pal, Sumanta K.
    Chowdhury, Simon
    Harshman, Lauren C.
    Crabb, Simon J.
    Wong, Yu-Ning
    Yu, Evan Y.
    Powles, Thomas
    Moshier, Erin L.
    Ladoire, Sylvain
    Hussain, Syed A.
    Agarwal, Neeraj
    Vaishampayan, Ulka N.
    Recine, Federica
    Berthold, Dominik
    Necchi, Andrea
    Theodore, Christine
    Milowsky, Matthew I.
    Bellmunt, Joaquim
    Rosenberg, Jonathan E.
    CANCER, 2015, 121 (15) : 2586 - 2593
  • [5] Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder
    Blick, Christopher
    Hall, Peter
    Pwint, Thinn
    Al-Terkait, Faisal
    Crew, Jeremy
    Powles, Thomas
    Macaulay, Valentine
    Munro, Nicholas
    Douglas, David
    Kilbey, Neviana
    Protheroe, Andrew
    Chester, John D.
    CANCER, 2012, 118 (16) : 3920 - 3927
  • [6] Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer (vol 354, pg 533, 1999)
    LANCET, 1999, 354 (9190): : 1650 - 1650
  • [7] Gemcitabine/cisplatin versus methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive bladder cancer: A systematic review and meta-analysis
    Cui Yu
    Chen Hequn
    Chen Jinbo
    Zeng Feng
    Zu Xiongbing
    Ding Jian
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (06) : 1260 - 1265
  • [8] TOLERANCE AND OUTCOMES OF NEOADJUVANT DOSE-DENSE METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN FOR MUSCLE-INVASIVE BLADDER CANCER AT AN AUSTRALIAN TERTIARY REFERRAL CENTRE
    Mak, Blossom
    Sved, Paul
    Vasilaras, Arthur
    Grimison, Peter
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 45 - 45
  • [9] TOLERANCE AND OUTCOMES OF NEOADJUVANT DOSE-DENSE METHOTREXATE, VINBLASTINE, DOXORUBICIN, CISPLATIN FOR MUSCLE-INVASIVE BLADDER CANCER AT AN AUSTRALIAN TERTIARY REFERRAL CENTRE
    Mak, B.
    Sved, P.
    Vasilaras, A.
    Grimison, P.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 61 - 62
  • [10] Comparative effectiveness of gemcitabine plus cisplatin (GC) versus methotrexate, vinblastine, doxorubicin, plus cisplatin (MVAC) as neoadjuvant therapy for muscle-invasive bladder cancer (MIBC).
    Galsky, Matt D.
    Harshman, Lauren Christine
    Crabb, Simon J.
    Wong, Yu-Ning
    Yu, Evan Y.
    Chowdhury, Simon
    Powles, Thomas
    Pal, Sumanta Kumar
    Moshier, Erin L.
    Ladoire, Sylvain
    Hussain, Syed A.
    Agarwal, Neeraj
    Vaishampayan, Ulka N.
    Recine, Federica
    Berthold, Dominik
    Necchi, Andrea
    Theodore, Christine
    Milowsky, Matthew I.
    Bellmunt, Joaquim
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345